Home/Filings/4/0001193125-25-288432
4//SEC Filing

Arens Timothy J. 4

Accession 0001193125-25-288432

CIK 0000924717other

Filed

Nov 18, 7:00 PM ET

Accepted

Nov 19, 6:06 PM ET

Size

20.5 KB

Accession

0001193125-25-288432

Insider Transaction Report

Form 4
Period: 2025-11-19
Arens Timothy J.
General Manager - IVD
Transactions
  • Disposition to Issuer

    Common Stock

    2025-11-1967,2990 total
  • Disposition to Issuer

    Employee Stock Option (right to buy)

    2025-11-1910,6530 total
    Exercise: $56.63Exp: 2025-11-27Common Stock (10,653 underlying)
  • Disposition to Issuer

    Employee Stock Option (right to buy)

    2025-11-1915,6680 total
    Exercise: $42.00Exp: 2026-11-26Common Stock (15,668 underlying)
  • Disposition to Issuer

    Employee Stock Option (right to buy)

    2025-11-1918,3370 total
    Exercise: $43.93Exp: 2028-11-30Common Stock (18,337 underlying)
  • Disposition to Issuer

    Employee Stock Option (right to buy)

    2025-11-1926,5480 total
    Exercise: $33.64Exp: 2030-12-04Common Stock (26,548 underlying)
  • Disposition to Issuer

    Employee Stock Options (right to buy)

    2025-11-1917,8830 total
    Exercise: $37.44Exp: 2027-11-30Common Stock (17,883 underlying)
  • Disposition to Issuer

    Employee Stock Option (right to buy)

    2025-11-192,6150 total
    Exercise: $40.01Exp: 2026-05-13Common Stock (2,615 underlying)
  • Disposition to Issuer

    Employee Stock Option (right to buy)

    2025-11-1925,0160 total
    Exercise: $36.13Exp: 2029-11-30Common Stock (25,016 underlying)
Footnotes (3)
  • [F1]Pursuant to that certain Merger Agreement, dated as of May 28, 2024, by and among the Surmodics, Inc. (the "Issuer"), BCE Parent, LLC, ("Parent"), and BCE Merger Sub, Inc. ("Merger Sub"), Merger Sub merged with and into the Issuer (the "Merger"), with Issuer surviving the Merger as a wholly owned subsidiary of Parent. At the effective time of the Merger (the "Effective Time"), each share of the Issuer's common stock, par value $0.05 per share ("Common Stock"), that was issued and outstanding immediately prior to the Effective Time was automatically cancelled and converted into the right to receive $43.00 per share in cash, without interest and subject to any applicable tax withholdings (the "Merger Consideration"). All outstanding restricted stock units ("RSUs") held by the reporting person vested immediately prior to the Effective Time and the reporting person is entitled to receive the Merger Consideration for such vested RSUs.
  • [F2]As a result of the Merger, the reporting person no longer beneficially owns, directly or indirectly, any shares of Common Stock.
  • [F3]Pursuant to the Merger Agreement, at the Effective Time, this unexercised stock option ("Option") was cancelled and automatically converted into the right to receive an amount in cash (without interest) equal to the product of (a) the aggregate number of shares of Common Stock subject to the Option immediately prior to the Effective Time, multiplied by (b) the excess, if any, of the Merger Consideration over such Option's applicable per share exercise price, subject to any required tax withholdings.

Documents

1 file

Issuer

SURMODICS INC

CIK 0000924717

Entity typeother

Related Parties

1
  • filerCIK 0001506586

Filing Metadata

Form type
4
Filed
Nov 18, 7:00 PM ET
Accepted
Nov 19, 6:06 PM ET
Size
20.5 KB